Related Experiment Videos
L-671,329, a new antifungal agent. II. Structure determination
C F Wichmann1, J M Liesch, R E Schwartz
1Department of Natural Products Research, Merck Sharp & Dohme Research Laboratories, Rahway, N.J. 07065-0900.
The Journal of Antibiotics
|February 1, 1989
Summary
A novel lipopeptide antifungal agent, L-671,329, was identified from filamentous fungus ATCC 20868. This compound is structurally similar to echinocandin B, suggesting potential therapeutic applications.
Area of Science:
- Mycology
- Natural Products Chemistry
- Antimicrobial Drug Discovery
Background:
- Filamentous fungi are a prolific source of bioactive natural products.
- Antifungal agents are crucial for treating invasive fungal infections.
- Echinocandin B is a known antifungal agent with a cyclic lipopeptide structure.
Purpose of the Study:
- To isolate and elucidate the structure of a novel antifungal compound from a fungal strain.
- To characterize the chemical properties and potential applications of the isolated compound.
Main Methods:
- Spectroscopic data analysis (e.g., NMR, Mass Spectrometry) was used for structural elucidation.
- Isolation of the compound L-671,329 from the filamentous fungus ATCC 20868.
- Comparison of the novel compound's structure with known antifungal agents.
Main Results:
- The structure of compound L-671,329 was determined to be a lipopeptide.
- Compound L-671,329 was isolated from the filamentous fungus ATCC 20868.
- L-671,329 was identified as a structural analog of echinocandin B.
Conclusions:
- A new lipopeptide antifungal agent, L-671,329, has been discovered.
- The structural similarity to echinocandin B suggests L-671,329 may possess antifungal activity.
- Further research into L-671,329's efficacy and mechanism of action is warranted.